首页> 外文期刊>Journal of Heterocyclic Chemistry: The International Journal of Heterocyclic Chemistry >SYNTHESIS OF DIALKYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(HETEROARYL)PYRIDINE-3,5-DICARBOXYLATES AS CALCIUM CHANNEL ANTAGONISTS
【24h】

SYNTHESIS OF DIALKYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(HETEROARYL)PYRIDINE-3,5-DICARBOXYLATES AS CALCIUM CHANNEL ANTAGONISTS

机译:钙通道拮抗剂合成二烷基1,4-二氢-2,6-二甲基-4-(杂芳基)吡啶-3,5-二羧酸酯

获取原文
获取原文并翻译 | 示例
           

摘要

The Hantzsch condensation of the heteroarylcarboxaldehydes 3a-c with alkyl acetoacetates 4a-c and alkyl 3-aminocrotonates 5a-b afforded the respective dialkyl 1,4-dihydro-2,6-dimethyl-4-(heteroaryl)-pyridine-3,5-dicarboxylates 6a-f possessing a C-4 4-quinolinyl, 8-quinolinyl or 1-oxido-4-pyridinyl substituent. Calcium channel antagonist structure-activity relationships acquired indicate that i) the position of the quinolyl nitrogen atom was not a determinant of activity, ii) increasing the size of the C-3 and C-5 alkyl ester substituents decreases potency and iii) a C-4 1-oxido-4-pyridinyl substituent abolishes activity. The most active, and equipotent C-4 4-quinolinyl 6a and 8-quinolinyl 6b analogs, were approximately 8-fold less potent calcium channel antagonists than the reference drug nifedipine. [References: 15]
机译:杂芳基羧酸醛3a-c与乙酰乙酸烷基酯4a-c和3-氨基巴豆酸烷基酯5a-b的汉茨缩合反应分别得到二烷基1,4-二氢-2,6-二甲基-4-(杂芳基)-吡啶-3,5。 -二羧酸酯6a-f具有C-4 4-喹啉基,8-喹啉基或1-氧化-4-吡啶基取代基。获得的钙通道拮抗剂结构-活性关系表明i)喹啉基氮原子的位置不是活性的决定因素,ii)增加C-3和C-5烷基酯取代基的大小会降低效力,并且iii)C -4 1-氧化-4-吡啶基取代基取消活性。与参考药物硝苯地平相比,活性最高,等价的C-4 4-喹啉基6a和8-喹啉基6b类似物的钙通道拮抗剂效价低约8倍。 [参考:15]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号